Floatz logo

28 assets in Malignant Mesothelioma

Therapeutic assets addressing Malignant Mesothelioma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Cis-Diamminedichloroplatinum Ii
Malignant Mesothelioma
Dr Jean Yannis PERENTESP2BB (68)
Cyclophosphamide
Malignant Mesothelioma
M.D. Anderson Cancer CenterP2BB (67)
Photofrin Ii
Malignant Mesothelioma
Roswell Park Cancer InstituteP1CC (47)
prt3645
Malignant Mesothelioma
Prelude TherapeuticsP1CC (47)
a2b543
Malignant Mesothelioma
A2 Biotherapeutics Inc.P1/2CC (45)
a2b694
Malignant Mesothelioma
A2 Biotherapeutics Inc.P1/2CC (45)
Atezolizumab
Malignant Mesothelioma
Cancer Research UKP1/2CC (45)
Bemcentinib
Malignant Mesothelioma
BerGenBio ASAP1CC (45)
Enzalutamide
Malignant Mesothelioma
Novartis PharmaceuticalsP1/2CC (45)
Fludarabine
Malignant Mesothelioma
M.D. Anderson Cancer CenterP1/2CC (45)
Gavo-Cel
Malignant Mesothelioma
TCR2 TherapeuticsP1/2CC (45)
htl0039732 capsules
Malignant Mesothelioma
Cancer Research UKP1/2CC (45)
Ipilimumab
Malignant Mesothelioma
TCR2 TherapeuticsP1/2CC (45)
Nivolumab
Malignant Mesothelioma
TCR2 TherapeuticsP1/2CC (45)
tc-510
Malignant Mesothelioma
TCR2 TherapeuticsP1/2CC (45)
Tulmimetostat
Malignant Mesothelioma
Novartis PharmaceuticalsP1/2CC (45)
Clostridium Novyi-Nt
Malignant Mesothelioma
M.D. Anderson Cancer CenterP1CC (43)
Doxycycline
Malignant Mesothelioma
M.D. Anderson Cancer CenterP1CC (43)
ism6331
Malignant Mesothelioma
InSilico Medicine Hong Kong LimitedP1CC (43)
Pembrolizumab
Malignant Mesothelioma
M.D. Anderson Cancer CenterP1CC (43)
Ucmym802
Malignant Mesothelioma
UTC Therapeutics Inc.P1CC (43)
ca9hu-1
Malignant Mesothelioma
Mabpro, a.s.P1CC (41)
nm32-2668
Malignant Mesothelioma
Numab Therapeutics AGP1CC (41)
sw-682
Malignant Mesothelioma
SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, GermanyP1CC (41)
Synkir-110, Autologous T Cells Transduced With Mesothelin Kir-Car
Malignant Mesothelioma
Verismo TherapeuticsP1CC (41)
Anti-Pd-L1 Monoclonal Antibody Ck-301
Malignant Mesothelioma
Checkpoint Therapeutics, Inc.P1NR ()
Tyk-01054
Malignant Mesothelioma
TYK Medicines, IncP1/2NR ()